The authors are in the Cancer Genomics Program, Department of Oncology, University of Cambridge and Cambridge University Hospitals National Health Service Foundation Trust, Cambridge CB2 2XZ, UK. cc234@cam.ac.uk
Findings over the last year or so have built the case that microRNAs might contribute to cancer. Three studies now definitively show this to be the case and also suggest that these small RNAs could be used to categorize tumors.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
